Arrythmias + Devices Flashcards

1
Q

risk factors for AFib

A
Age 
valvular heart Dz 
dilated cardiomyopathy 
arteriosclerotic ht dz 
genetics 
COPD 
Anemia 
HTn DM 
CKD 
obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

triggering factors for AF

A
thyrotoxicosis 
pericarditis 
chest trauma
sx
EtOH intake 
EtOH withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AF epidemiology

A

more common men, caucasians

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pathophysiology of AF

A

sleeves of arrhythmogenic atrial tissue extends into pulmonary veins

they attempt to pace the heart, lots of different cells lead to the pace of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

electrical remodeling in AFib

A

atrial electrical and structural remodeling occurs which promotes the continuation of Afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

classification of AFib

A
  1. persistent AF
  2. Paroxysmal AF
  3. permentant AF
    4, Lone AF
  • AFib secondary to another cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

persistent AFib

A

Fib that fails to self terminate within 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

paroxysmal AFib

A

2+ episodes of self terminating or intermittent AF lasting less than 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

permanent AF

A

lasts > 1yr

cardio version has not been attempted or failed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lone AF

A

young individuals <60

absence of structural heart disease

typically occurs in young males, associated with specific trigger

greater number of foci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clinical presentation of AF

why do they range in symptoms?

A

related to perfusion and ventricular control

uncontrolled (>100 bpm) causes backing up to lunch, decreased perfusion of brain and kidney

controlled (<100 bpm) no HF issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diagnosis of Afib

A
EKG 
TTE 
Cardiac Enzymes and BNP
TSH and free T4
Baseline CBC, renal function, glucose level, UA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EKG evaluates for AFib AND

A

LVH
Evidence of prior MI
conduction system issues
establishes baseline QT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TTE

A

transTHORACIC

looks for valvular dz, atrial size, LVH, systolic and diastolic issues

unable to exclude L. atrial thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

tx of unstable AFib

A

immediate synchronized cardio version

load medications and pt still remains unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

management of a stable patient

A
  1. telemetry bed
  2. rate control if RVR
  3. Begin evaluation
  4. anti coagulate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

rate control of RVR stable AF

A

cardizem (10-20 mg IV bolus)

Metoprolol (cardiac ischemia and infarction)

Digoxin (hypotension)

Amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

immediate anticoagulation for Afib

A

heparin IV infusion (kidney issues or recent bleeding0

LMWH (pregnancy, DOC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

other diseases that we need to consider when treating AFib

A

MI

Wet Lungs - Lasix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tx strategies of new onset AFib

A

Rhythm control v. rate control

embolization risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

rate control strategy

A

get resting HR to 80 ppm

recommended 65+

typically use BB or non-DHP CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

other medications used in rate control

A

acute systolic heart failure, treated with amiodarone or digoxin

must be careful of amiodarone - cardio version

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pre-excitation syndrome

A

AV node blockage will promote tachyarrhythmias via accessory pathway

CCB and dig are C/I = amiodarone is DOC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

rhythm control strategy

A

convert AF to SNR and medications to keep patient in NSR

methods: Cardioversion, radio frequency catheter ablation, maze procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when should cardio version most successful

A

AFib of less than 7 days in duration - less chance of remodeling

its must be anti-coagulated for 3+ weeks or TEE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

cardioversion procedure

A

electrolytes K and O2 are normalized and pt is npc for 6 hrs

conscious sedation

electrical shock (120-200 j) via biphasic defibrillator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

cardio version is highly recommended in….

A

younger patients with onset AF of short duration

function improves almost immediately after cardio version

anticoagulation should continue for at least 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

shocking chronic AFib?

A

AFFIRM and RACE

no benefit for patients with cardioversion in tx of chronic AF

pt plan needs to be individualized bc risks and benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

RF catheter ablation indicated

A

lifestyle impairing aFIB and intolerability of at least 1 anti-rhythm agent

NOT always a cure but more effective than pharm tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

when is RF ablation most successful?

A

AFib of less than 7 days in duration - less chance of remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

process of RF ablation

A

going thru intra-atrial septum

electrophysiologist makes a 3d map of atria using an electromagnetic probe

burns all small lesions in tissue to isolate pulmonary veins

possible meds can be taken to reduce recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

complications of catheter ablation

A

cardiac perforation
tamponade
atrial flutter
vascualr access complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

RF catheter ablation mortality benefit

A

NO mortality benefit and NO change in anticoagulation

BUT they can improve rate/lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

anti-arrhythmics used in AF therapy

A
  1. Amniodarone *
  2. Dronedarone *
  3. Sotalol
  4. Dofetilide
  • use with caution bc lots of drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

amniodarone brand and use

A

Pacerone, Cordarone

safe in persistent AF, better than other anti-arrythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

in what patients is amniodarone the DOC?

A

patients with cardiac dz (CAD, systolic or diastolic HF)

decreased pro-arrhythmic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Class Ic anti-arrhythmics use

A

Propafenone and flecanide

indicated for patients with AF and SCT without structural heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Dronedarone brand and use

A

Multaq

paroxysmal AF or after conversion of persistent AF

associated with INCREASED mortality in pts with PERMANENT AF

39
Q

Dronedarone special patient population

A

properties of all 4 classes

paroxysmal or persistent AF/flutter

associated CV risk factors who are in sinus rhythm or will be converted

40
Q

Dronedarone is CI in

A

permanent AF

class IV heart failure or recent episode of ANY HF

41
Q

sotalol brand and s.e.

A

Betapace

class 3, QT interval prolongation and torsdae de pointes

MUST monitor QT and electrolytes

42
Q

Sotalol is CI in, why?

A

HF pts, pts with prolonged QT

pro-arrhythmic effects are increased in HF

43
Q

Dofetilide brand and use

A

Tikosyn

must hospitalize when starting

indicated for maintenance of sinus rhythm and conversion of AF in persistent AF

44
Q

Dofetilide has NO effect on…

A
cardiac output
cardiac index 
stroke volume index
systemic vascular resistance in VTACH 
HF 
LVEF
45
Q

Thrombus formation in AF

when and why

A

concerned about thrombus formation in pts with AF >48hrs

enough time for a thrombus to form and dislodge can go to brain for stroke

46
Q

AF and stroke risk

A

MANY strokes in US are caused by AF

+ larger and more likely to undergo conversion to hemorrhagic

(more likely to occur and more likely to have a worse outcome)

chances of AF are increased in valvular dz

increased in women, increasing age

47
Q

T or F

Patients with persistent AF are more likely to get a stroke than those with paroxysmal AF

A

FALSE

there is NO difference in rate of stroke bt paroxysmal and persistent AF

ALL AF pts should be anti-coagulated

48
Q

what do we use to calculate anticoagulation risk?

A

CHADS2 VAS

49
Q

CHADS 2 VAS

A
C- congestive HF 
H- HTN
A- >75 
D- DM 
S- secondary prevention of embolic events (+2)

V- vascular dz
A- >65
S- sex (women +1)

50
Q

CHADS2VAS score 0-1

A

ASA alone

51
Q

CHADS2VAS score 2

A

individualize ASA v anticoagulation

52
Q

CHADS2VAS score 3+

A

anti-coagulate with warfarin or NOAC

53
Q

risk of CHADS2VAS score?

A

bleeding risk

use HAS-BLED

54
Q

HAS-BLED

A
H - HTN
A- Abnormal renal/liver fxn
S- stroke 
B - bleeding history
L - labile INRs
E - elderly (65+) 
D- drugs (antiplatelet or alcohol) 

each of these is +1

55
Q

what HAS-BLED score qualifies high risk of bleeding

A

> 3

use caution and review anticoagulation

56
Q

HAS-BLED or CHADS2VAS

A

risk of major bleeding can exceed benefits but no study has shown

57
Q

Warfarin/Coumadin, dose adjusted to/how

A

INR 2-3

overlap w IV heparin, 5 days

medium dose, check PT/INR after 48 hrs and adjust from there

58
Q

advantages of warfarin

A

Coumadin/Jantoven

cheap, insurance coverage
safe in CKD/renal failure

59
Q

disadvantages of warfarin

A

many Drug/Drug interactions

narrow therapeutic index (close monitoring)

requires a lot of diet control

60
Q

long-term Anti-Coagulation agents in AF

A

Warfarin/Coumadin/Jantoven

NOACs (Apixaban, Rivaroxaban, Dabigatran, Edoxaban)

61
Q

NOACs use in AF

A

NON-VALVULAR A-FIB

considered superior to warfarin if persons have CHADS2VAS > 2

if pt has valvular dz then warfarin is superior

62
Q

Apixaban (Eliquis)

A

5mg bid

Xa inhibitor

dose adjusted to 2.5 if: CR >1.5, >80 age, wt <60 kg

safest NOAC for the kidney ***

63
Q

Rivaroxaban (Xarelto)

A

Xa inhibitor must dose adjust

can’t use in CKD IV (GFR < 30)

64
Q

Dabigatran (Pradaxa)

A

direct thrombin inhibitor

reversal agent is available (COSTLY)

used until stage IV CKD (GFR < 30)

65
Q

dabigatran TRADE

A

Pradaxa

66
Q

rivaroxaban TRADE

A

Xarelto

67
Q

apixaban TRADE

A

Eliquis

68
Q

Edoxaban (Savaysa) kidney

A

dose adjust if GFR < 50

can’t be used in GFR >90 or GFR <30

69
Q

watchman device

what is it, who gets it

A

given to pts who can’t be maintained on anticoagulation

umbrella device deployed to L ATRIAL APPENDAGE, allows tissue to grow over the device and seal off the appendage

blocks the “nook” where clots like to form

70
Q

NSVT

A

“10 beat run of VT”

non-sustained V-Tach that can be a marker for sustained ventricular dysrhythmia

typically asymptomatic

immediate 12 lead EKG

71
Q

reversible causes of NSVT (7)

A

electrolyte derangements (esp. K, Mg)

myocardial ischemia (troponin)

hypoxia

anemia

hypotension

heart failure

ADRs

72
Q

a single episode of NSVT diagnostic testing

A

12 lead EKG and evaluation of reversible causes is enough

73
Q

symptomatic or recurrent NSVT

A

2D echo

stress testing

74
Q

physiologic response to stress that may be seen in many illnesses

A

sinus tachycardia

75
Q

symptoms of Sinus Tach

A

may have palpitations

majority of symptoms are usually related to underlying illness

if sinus tach is from underlying cause, tx is aimed at that

76
Q

Inappropriate Sinus Tachycardia definition and epidemiology (AKA)

A

aka chronic non-paroxysmal sinus tach

dx of exclusions in persons without structural heart disease or other cause for sinus tach

exaggerated HR response to exercise

often young. female patients

77
Q

Inappropriate Sinus Tachycardia patho and dx/tx

A

hyperactivity of SA node, depressed vagal response, and beta-adrenergic hypersensitivity

confirm with 12 lead EKG

tx with low dose metoprolol

ivabridine is more efficacious (off lable)

78
Q

Inappropriate Sinus Tachycardia v. Atrial Tach

A

sinus tach is in response to stress or illness

a tach is paroxysmal and unrelated to events

79
Q

POTS def + epidemiology

A

exaggerated HR response to STANDING but rare orthostasis

teen and young adult women

80
Q

POTS proposed mechanisms

A
genetics 
hypovolemia 
cardiac deconditioning 
distal extremity denervation 
decreased venous return
81
Q

POTS symptoms

A

CNS (dizziness, weakness, blurred vision, fatigue while standing)

orthostatic (palpitations, tremors, anxiety)

GI (n/c/d, cramps)

82
Q

defibrillation

A

cardioversion with LOTS of joules

usually used in VENTRICULAR issues

83
Q

cardioversion

A

synchronized v. unsynchronized

fewer joules, ATRIAL issues

84
Q

synchronized

A

uses patients natural heartbeat

finds R wave and shocks them at just the right time

85
Q

types of pacemakers (3 types + 3 subtypes)

A
Transcutaneous (temp + painful) 
Transvenous (temp + NOT painful) 
permenant 
-single 
-dual chamber
-biventricular
86
Q

single permanent pacemaker

A

one lead connected to either atria or ventricles

87
Q

dual chamber permanent pacemaker

A

two loads

one to atria and one to ventricle

88
Q

biventricular

A

3 leads, one to RA and one to ea. ventricle

89
Q

pacemaker + ICD when?

A

brugada
patients prone to VTach, VFib
EF < 30%

90
Q

Pacemaker code

A

first letter: chamber being PACED (A, V, D)
2nd letter: chamber being SENSED (A, V, D, O)
3rd letter: response mode (I, T, D, O)

fourth = programmability and rate 
fifth= IF ICD
91
Q

response mode of pacemaker letter meanings

A

I = inhibited by native beat

T = triggered by native beat (addative)

D= triggered after sensed atrial event but inhibited after ventricular response

O= none

92
Q

permanent pacemaker placement

A

general anesthesia and run wires to R heart via veins (cephalic, axillary, subclavian)

placed in SubQ pocket

return for wound check, interrogation

battery life 7-10 years

93
Q

pacer precautions

A

patients with pacemakers CAN”Thave MRIs

ACLS defib can be safely performed